Pentobarbital Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00312 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | obesity disorder | KG + DL |
| 2 | manic bipolar affective disorder | KG + DL |
| 3 | hypervitaminosis | KG + DL |
| 4 | proximal 16p11.2 microdeletion syndrome | KG + DL |
| 5 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 6 | obsolete hypertelorism (disease) | KG + DL |
| 7 | major affective disorder | KG + DL |
| 8 | frontorhiny | KG + DL |
| 9 | monogenic obesity | KG + DL |
| 10 | trichotillomania | KG + DL |
| 11 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 12 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 13 | specific developmental disorder | KG + DL |
| 14 | Tourette syndrome | KG + DL |
| 15 | migraine disorder | KG + DL |
| 16 | attention deficit-hyperactivity disorder | KG + DL |
| 17 | epilepsy, childhood absence, susceptibility to | KG + DL |
| 18 | migraine with brainstem aura | KG + DL |
| 19 | benign paroxysmal torticollis of infancy | KG + DL |
| 20 | agoraphobia | KG + DL |
| 21 | absence epilepsy | KG + DL |
| 22 | striatal degeneration, autosomal dominant | KG + DL |
| 23 | bipolar disorder | KG + DL |
| 24 | chondromyxoid fibroma | KG + DL |
| 25 | faciodigitogenital syndrome | KG + DL |
| 26 | Malan overgrowth syndrome | KG + DL |
| 27 | alcohol withdrawal | KG + DL |
| 28 | distal 17p13.3 microdeletion syndrome | KG + DL |
| 29 | anxiety | KG + DL |
| 30 | progressive encephalopathy with leukodystrophy due to DECR deficiency | KG + DL |
| 31 | familial mesial temporal lobe epilepsy with febrile seizures | KG + DL |
| 32 | visual epilepsy | KG + DL |
| 33 | atrophoderma vermiculata | KG + DL |
| 34 | hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | KG + DL |
| 35 | restless legs syndrome | KG + DL |
| 36 | ventricular tachycardia | KG + DL |
| 37 | fatty liver disease | KG + DL |
| 38 | trigeminal nerve neoplasm | KG + DL |
| 39 | phencyclidine abuse | KG + DL |
| 40 | Wernicke-Korsakoff syndrome | KG + DL |
| 41 | obsolete bundle branch block | KG + DL |
| 42 | reading seizures | KG + DL |
| 43 | thinking seizures | KG + DL |
| 44 | eating seizures | KG + DL |
| 45 | startle epilepsy | KG + DL |
| 46 | micturation-induced seizures | KG + DL |
| 47 | audiogenic seizures | KG + DL |
| 48 | orgasm-induced seizures | KG + DL |
| 49 | ulerythema ophryogenesis | KG + DL |
| 50 | catecholaminergic polymorphic ventricular tachycardia | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.